XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Varex Equity
Total Varex Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests
Stockholders' equity, outstanding, beginning balance at Sep. 30, 2022 $ 546.7 $ (28.1) $ 533.4 $ (28.1) $ 0.4 $ 469.1 $ (34.6) $ 0.1 $ 63.8 $ 6.5 $ 13.3
Common stock, shares, outstanding, beginning balance (in shares) at Sep. 30, 2022         40,100,000            
Increase (Decrease) in Stockholders' Equity                      
Net (loss) income 3.2   3.1           3.1   0.1
Share-based compensation 3.3   3.3     3.3          
Other (0.1)         0.1     (0.1)   (0.1)
Stockholders' equity, outstanding, ending balance at Dec. 30, 2022 525.0   511.7   $ 0.4 437.9   0.1 73.3   13.3
Common stock, shares, outstanding, ending balance (in shares) at Dec. 30, 2022         40,100,000            
Stockholders' equity, outstanding, beginning balance at Sep. 29, 2023 $ 581.0   567.7   $ 0.4 450.4   (1.2) 118.1   13.3
Common stock, shares, outstanding, beginning balance (in shares) at Sep. 29, 2023 40,529,573       40,500,000            
Increase (Decrease) in Stockholders' Equity                      
Net (loss) income $ (0.4)   (0.5)           (0.5)   0.1
Common stock issued upon vesting of restricted shares (in shares)         200,000            
Shares withheld on vesting of restricted stock (1.0)   (1.0)     (1.0)          
Shares withheld on vesting of restricted stock (in shares)         (100,000)            
Share-based compensation 3.7   3.7     3.7          
Foreign currency translation adjustments (1.0)   (1.0)         (1.0)      
Business acquisitions 0.7                   0.7
Other 0.0         0.1     (0.1)    
Stockholders' equity, outstanding, ending balance at Dec. 29, 2023 $ 583.0   $ 568.9   $ 0.4 $ 453.2   $ (2.2) $ 117.5   $ 14.1
Common stock, shares, outstanding, ending balance (in shares) at Dec. 29, 2023 40,618,590       40,600,000